The board of directors of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. announced that Mr. LI Xuechen has been appointed as the chairman of the nomination committee of the Company; Mr. TANG Jianxin ('Mr. Tang') has been appointed as a member of the Nomination Committee; and Ms. XIANG Ling (`Ms. Xiang') has been appointed as a member of the audit committee of the Company with effect from 3 October 2022. The board (the ``Board') of directors of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. has received the written resignations tendered by Mr. Eddy HUANG (`Mr. Huang''), a non-executive Director, and Mr. ZHAO Dayao (`Mr. Zhao'), an independent non-executive Director, with effect from 30 September 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.68 HKD | -0.21% | -7.10% | +2.00% |
05-08 | Yichang HEC Still Negotiating Merger Deal with Sunshine Lake Pharma | MT |
04-09 | Yichang Hec Changjiang Pharmaceutical Updates on Possible Merger with Sunshine Lake Pharma | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.00% | 1.09B | |
+39.22% | 731B | |
+32.33% | 586B | |
-7.85% | 348B | |
+15.48% | 319B | |
-0.12% | 273B | |
+13.52% | 235B | |
+7.45% | 202B | |
-6.99% | 203B | |
-3.37% | 158B |
- Stock Market
- Equities
- 1558 Stock
- News YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
- Yichang Hec Changjiang Pharmaceutical Co., Ltd. Announces Committee Appointments